Business
VIVIMIND(TM) granted certificate of free sale as food supplement in Italy - Premarket notification filed in the U.S.
ECUBLENS, SWITZERLAND, July 16 /CNW Telbec/ - BELLUS Health (International) Limited, a wholly own...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\nECUBLENS, SWITZERLAND, July 16 /CNW Telbec/ - BELLUS Health\n(International) Limited, a wholly owned subsidiary of BELLUS Health Inc.\n(BELLUS Health, TSX: BLU), today announced that the Italian Ministry of Health\nhas granted a certificate of free sale for VIVIMIND(TM) (homotaurine) as a\nfood supplement. A certificate of free sale in Italy permits the commercial\nsale of the product in that country. This certificate opens up means by which\nto pursue marketing and sales authorization in the other member states of the\nEuropean Union.\n\n\nVIVIMIND(TM) is a patented, amino acid, present in some species of algae,\nto support cognitive function and memory. VIVIMIND(TM) is now available in\nCanada. Recently published data in a peer-reviewed journal show that\nhomotaurine slows the loss of volume in the hippocampus, a region of the brain\nassociated with memory, and has a beneficial effect on cognition(1).\n\n\nU.S. Regulatory Update\n\n\nWith respect to the United States, OVOS Natural Health Inc., a wholly\nowned subsidiary of BELLUS Health Inc., has filed a premarket notification of\na New Dietary Ingredient for homotaurine with the U.S. Food and Drug\nAdministration, and is pursuing mandatory associated regulatory activities to\nobtain marketing approval for homotaurine as a dietary supplement.\n\n\nAbout BELLUS Health Inc.\n\n\nBELLUS Health is a global health company focused on the development and\ncommercialization of products to provide innovative health solutions to\naddress critical unmet needs.\n\n\nTo Contact BELLUS Health Inc.\n\n\nFor additional information on BELLUS Health and its drug development\nprograms, please call the Canada and United States toll-free number\n1-877-680-4500 or visit the Web Site at www.bellushealth.com.\n\n\n(1) S. Gauthier, P. S. Aisen, S. H. Ferris, D. Saumier, A. Duong,\n\n\nD. Haine, et al. (2009). Effect of Tramiprosate in Patients with\n\n\nMild-to-Moderate Alzheimer's Disease: Exploratory Analyses of the MRI\n\n\nSub-group of the Alphase Study. Journal of Nutrition, Health and Aging,\n\n\nVolume 13, Number 6/June 2009, 550-557.\n\n\nCertain statements contained in this news release, other than statements\nof fact that are independently verifiable at the date hereof, may constitute\nforward-looking statements. Such statements, based as they are on the current\nexpectations of mana...